Among the markers used to distinguish between urothelial and prostate cancers, prostate-specific antigen (PSA) and prostate-specific acid phosphatase (PSAP) are most commonly used to establish the prostatic origin of tumors; however, their expression is significantly decreased in poorly differentiated prostatic cancers [1,2]. Here, PSAP is linked to prostate cancer.